Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich protein 18 (PRR18) is a protein-coding gene, most prominently expressed in the central nervous system, where it plays a role in neuronal development, particularly in mediating neuronal differentiation and neurite outgrowth during brain development. It is a small protein (117–297 amino acids) characterized by a high content of proline residues, but its precise biochemical function remains largely uncharacterized. There is no evidence to classify PRR18 as a classical therapeutic target (such as receptor, enzyme, transporter, etc.), and there are no known drugs directly targeting this protein. Although it is associated with neuronal processes, well-defined links to specific diseases or safety concerns have not been reported in current major databases[1][2][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich protein 18 (PRR18).